Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

Sunshine Biopharma (SBFMW) Long-Term Debt Issuances (2016 - 2021)

Historic Long-Term Debt Issuances for Sunshine Biopharma (SBFMW) over the last 8 years, with Q3 2021 value amounting to $1.4 million.

  • Sunshine Biopharma's Long-Term Debt Issuances rose 16838.64% to $1.4 million in Q3 2021 from the same period last year, while for Dec 2021 it was $3.3 million, marking a year-over-year increase of 9820.86%. This contributed to the annual value of $3.3 million for FY2021, which is 9820.86% up from last year.
  • Per Sunshine Biopharma's latest filing, its Long-Term Debt Issuances stood at $1.4 million for Q3 2021, which was up 16838.64% from $768500.0 recorded in Q2 2021.
  • In the past 5 years, Sunshine Biopharma's Long-Term Debt Issuances ranged from a high of $1.4 million in Q3 2021 and a low of $25000.0 during Q2 2018
  • Its 5-year average for Long-Term Debt Issuances is $394378.0, with a median of $216000.0 in 2017.
  • Per our database at Business Quant, Sunshine Biopharma's Long-Term Debt Issuances plummeted by 8190.87% in 2018 and then soared by 142936.23% in 2020.
  • Over the past 5 years, Sunshine Biopharma's Long-Term Debt Issuances (Quarter) stood at $256121.0 in 2017, then tumbled by 30.89% to $177000.0 in 2018, then tumbled by 63.15% to $65230.0 in 2019, then skyrocketed by 1429.36% to $997603.0 in 2020, then skyrocketed by 40.34% to $1.4 million in 2021.
  • Its last three reported values are $1.4 million in Q3 2021, $768500.0 for Q2 2021, and $1.2 million during Q1 2021.